Grants and Contributions:
Title:
US Market Expansion
Agreement Number:
927798
Agreement Value:
$46,926.00
Agreement Date:
Apr 1, 2019 - Mar 31, 2020
Description:
Detail Market analysis of USA Healthcare organizations, in the North East of the United States, providing patient chronic care especially Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) and for which the organizations are facing high 30-day readmission rates (above 20%).
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Ottawa, Ontario, CA K1Y 2C5
Reference Number:
172-2019-2020-Q1-927798
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
827242579
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 32 days.
Amendment Date
Jan 21, 2020
Recipient's Legal Name:
Aetonix Systems Inc
Federal Riding Name:
Ottawa Centre
Federal Riding Number:
35075
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211
Amendments: